MPCC Annual Symposium
The 17th Annual Massachusetts Prostate Cancer Symposium — leading prostate cancer specialists provide up-to-date information on the latest in prostate cancer treatment and research — in user-friendly language!
17th Annual Massachusetts Prostate Cancer Symposium
Friday, May 16, 2014 – 7:30 AM – 2:00 PM
Marriott Newton — 2345 Commonwealth Avenue Newton, MA 02466
OPEN TO THE PUBLIC AT NO CHARGE
|10:15 AM – 11:15 AM
(Concurrent Educational Sessions I)
|11:30 AM – 12:30 PM
(Concurrent Educational Sessions II)
|A Conversation with Dr. Klein
An opportunity for an in-depth follow-up conversation with Dr. Klein based on the key elements of his keynote presentation.
Eric Klein, MD
Can Men with Prostate Cancer Ever Receive Testosterone Therapy?
Contemporary Management of Advanced Prostate CancerThis session will focus on the latest thinking, treatment and management of advanced disease, including an update on clinical trials underway for prostate cancer.
Genetic Research: Developments in prostate cancerGenetic research in prostate cancer continues to evolve. This session will highlight how genetics is creating new ways to match treatments to tumors more effectively.
Outreach to High-Risk Communities
|Consensus on PSA Testing for African American Men
Prostate cancer screening is one of the most controversial areas of management in modern medicine today. However, men at high risk for prostate cancer are often times not included in the debate. African Amer- ican men suffer the highest mortality rate from prostate cancer, which is the largest racial disparity for any type of major cancer. The Prostate Health Education Network (PHEN) issued a Consensus Statement on PSA Testing, signed by 26 leading prostate cancer experts, to provide clear guidance for men deemed to be at high risk for prostate cancer. This session will present and examine the PHEN Consensus Statement.
Navigating the Medical Experience: Best practices
Prostate Cancer and the Psyche
Treatment Options for Men Who Recur After Radiation
Imaging of Prostate Cancer: Creating your strategic plan
PRESENTATION OF THE CHARLES AUSTIN AWARD
The Charles Austin Award was established by the Massachusetts Prostate Cancer Coalition in 2006 to honor an outstanding member of its board of directors, Charles Austin. Mr. Austin, himself a prostate cancer survivor, has worked tirelessly to raise awareness of the risks of prostate cancer, particularly in the African-American community, and of the benefit of early detection and treatment options.
2014 Charles Austin Award Presented to William Tinney
- c/o Green Associates
200 Lincoln St, Suite 201
Boston MA 02111
- +1 (617) 482-3044, Ext. 28